Cargando…
Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice
BACKGROUND: Transient depletion of CD4(+) T cells results in tumor suppression and survival benefit in murine models; however, the tumor progression and recurrence still occur over more long-term monitoring of mice. Thus, we explored an additional strategy to enhance endogenous immune responses by a...
Autores principales: | Chen, Chang-Yu, Ueha, Satoshi, Ishiwata, Yoshiro, Yokochi, Shoji, Yang, De, Oppenheim, Joost J., Ogiwara, Haru, Shichino, Shigeyuki, Deshimaru, Shungo, Shand, Francis H. W., Shibayama, Shiro, Matsushima, Kouji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352494/ https://www.ncbi.nlm.nih.gov/pubmed/30696484 http://dx.doi.org/10.1186/s40425-019-0503-6 |
Ejemplares similares
-
TCR Repertoire Analysis Reveals Mobilization of Novel CD8(+) T Cell Clones Into the Cancer-Immunity Cycle Following Anti-CD4 Antibody Administration
por: Aoki, Hiroyasu, et al.
Publicado: (2019) -
Combination of anti‐CD4 antibody treatment and donor lymphocyte infusion ameliorates graft‐versus‐host disease while preserving graft‐versus‐tumor effects in murine allogeneic hematopoietic stem cell transplantation
por: Ueha, Satoshi, et al.
Publicado: (2017) -
First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors
por: Shitara, Kohei, et al.
Publicado: (2019) -
Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis
por: Aoki, Hiroyasu, et al.
Publicado: (2022) -
Macrophages in lung fibrosis
por: Ogawa, Tatsuro, et al.
Publicado: (2021)